Trading Ideas ResMed, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 05/12/2025 GMT			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

12-04	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

RESMED, INC.: A good level to buy	19/10/21
RESMED, INC.: Buy the stock in the USD 55.3 area	07/07/15
RESMED, INC.: Trading opportunity	15/02/13
RESMED, INC.: The share is well oriented	17/12/12

No results for this search

ResMed's innovation-driven success and prospects

October 31, 2025 at 08:55 am